289 related articles for article (PubMed ID: 24341787)
1. Oral cyclosporine treatment in dogs: a review of the literature.
Archer TM; Boothe DM; Langston VC; Fellman CL; Lunsford KV; Mackin AJ
J Vet Intern Med; 2014; 28(1):1-20. PubMed ID: 24341787
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporin A pharmacokinetics and efficacy in the treatment of atopic dermatitis in dogs.
Steffan J; Strehlau G; Maurer M; Rohlfs A
J Vet Pharmacol Ther; 2004 Aug; 27(4):231-8. PubMed ID: 15305852
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine and tacrolimus.
Vaden SL
Semin Vet Med Surg Small Anim; 1997 Aug; 12(3):161-6. PubMed ID: 9283240
[TBL] [Abstract][Full Text] [Related]
4. Concurrent administration of water-soluble vitamin E can increase the oral bioavailability of cyclosporine a in healthy dogs.
Fischer JR; Harkin KR; Freeman LC
Vet Ther; 2002; 3(4):465-73. PubMed ID: 12584684
[TBL] [Abstract][Full Text] [Related]
5. Improving the oral absorption of cyclosporine in malabsorbers: a review of the Neoral Compassionate Need Program.
Mueller EA; Kovarik JM; Pittrow D
Transplant Proc; 1998 Aug; 30(5):1691-3. PubMed ID: 9723246
[No Abstract] [Full Text] [Related]
6. The effect of particle size on bioavailability in cyclosporine preparations based on submicron dispersions.
Vrána A; Andrýsek T
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2001 Dec; 145(2):9-15. PubMed ID: 12426767
[TBL] [Abstract][Full Text] [Related]
7. Influence of food intake on the clinical response to cyclosporin A in canine atopic dermatitis.
Thelen A; Mueller RS; Linek M; Peters S; Stechmann K; Steffan J
Vet Rec; 2006 Dec; 159(25):854-6. PubMed ID: 17172483
[No Abstract] [Full Text] [Related]
8. More economical use of cyclosporine through combination drug therapy.
Daigle JC
J Am Anim Hosp Assoc; 2002; 38(3):205-8. PubMed ID: 12022403
[No Abstract] [Full Text] [Related]
9. Concurrent short-term use of prednisolone with cyclosporine A accelerates pruritus reduction and improvement in clinical scoring in dogs with atopic dermatitis.
Dip R; Carmichael J; Letellier I; Strehlau G; Roberts E; Bensignor E; Rosenkrantz W
BMC Vet Res; 2013 Sep; 9():173. PubMed ID: 24004561
[TBL] [Abstract][Full Text] [Related]
10. Opportunistic Invasive Cutaneous Fungal Infections Associated with Administration of Cyclosporine to Dogs with Immune-mediated Disease.
McAtee BB; Cummings KJ; Cook AK; Lidbury JA; Heseltine JC; Willard MD
J Vet Intern Med; 2017 Nov; 31(6):1724-1729. PubMed ID: 28887897
[TBL] [Abstract][Full Text] [Related]
11. Excipients and their role in absorption: Influencing bioavailability of cyclosporine by triglycerides and polyglycerol esters.
Andrysek T
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2006 Nov; 150(2):227-33. PubMed ID: 17426783
[TBL] [Abstract][Full Text] [Related]
12. Review of the pharmacokinetics, interactions and adverse reactions of cyclosporine in people, dogs and cats.
Robson D
Vet Rec; 2003 Jun; 152(24):739-48. PubMed ID: 12833934
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of a microemulsion formulation of cyclosporine in pediatric liver transplant recipients.
Cooney GF; Lum BL; Meligeni JA; Dunn SP
Transplant Proc; 1996 Aug; 28(4):2270-2. PubMed ID: 8769222
[No Abstract] [Full Text] [Related]
14. Pharmacokinetics of an oral solution of the microemulsion formulation of cyclosporine in maintenance pediatric liver transplant recipients.
Dunn S; Cooney G; Sommerauer J; Lindsay C; McDiarmid S; Wong RL; Chang CT; Smith HT; Choc MG
Transplantation; 1997 Jun; 63(12):1762-7. PubMed ID: 9210501
[TBL] [Abstract][Full Text] [Related]
15. Clinical interaction between grapefruit juice and cyclosporine: is there any interest for the hematologists?
Emilia G; Longo G; Bertesi M; Gandini G; Ferrara L; Valenti C
Blood; 1998 Jan; 91(1):362-3. PubMed ID: 9414309
[No Abstract] [Full Text] [Related]
16. Cyclosporine pharmacology.
Lee JI; Canafax DM
Transplant Proc; 1996 Aug; 28(4):2156-8. PubMed ID: 8769185
[No Abstract] [Full Text] [Related]
17. Neoral cyclosporine.
Canafax DM
Transplant Proc; 1996 Apr; 28(2):867. PubMed ID: 8623439
[No Abstract] [Full Text] [Related]
18. Bioequivalence study between two formulations of ciclosporin A (Cyclavance® oral solution and Atopica® soft capsules) following a single oral administration to dogs.
Navarro C; Séguy L; Vila M; Birckel P
BMC Vet Res; 2016 Mar; 12():54. PubMed ID: 26970736
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolic acid in patients with immune-mediated inflammatory diseases: From humans to dogs.
Klotsman M; Sathyan G; Anderson WH; Garden OA; Shivanand P
J Vet Pharmacol Ther; 2019 Mar; 42(2):127-138. PubMed ID: 30375004
[TBL] [Abstract][Full Text] [Related]
20. Alterations in activated T-cell cytokine expression in healthy dogs over the initial 7 days of twice daily dosing with oral cyclosporine.
Riggs C; Narayanan L; Mulligan C; Wills R; Mackin A; Fellman C; Thomason J; Archer T
J Vet Pharmacol Ther; 2019 Jul; 42(4):385-391. PubMed ID: 30933369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
